ACRO members conduct research in more than 115 countries and are leading the globalization of drug development.

ACRO provides a strong voice for the CRO industry in Washington on issues related to clinical research, HIT, research participation and ethics and more.

ACRO is active across Europe to ensure a favorable regulatory environment to conduct clinical research.

The CRO industry provides the new global infrastructure for drug development.

Stay Connected

Stay connected to the issues that affect you most. Subscribe, follow or become a fan of ACRO.

Key Issues

Explore the key issues ACRO and its members are focused on every day.

ACRO and the industry

Learn more about ACRO, its members and the CRO industry.

The Case for Globalization

ACRO Updates

January 03, 2012
ACRO Comments on Washington Post Article

December 01, 2011
Jeff McMullen Elected 2012 ACRO Chairman

October 06, 2011
ACRO Endorses Foreign Earnings Reinvestment Act

View All Updates